State Street’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

State Street’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-1,315,892	Closed	-$70.3M	–	3900
2016 Q1	$70.3M	Buy	1,315,892 +320,478	+32%	+$23.7M	0.01%	1002
2015 Q4	$112M	Buy	995,414 +98,449	+11%	+$10.8M	0.01%	784
2015 Q3	$106M	Sell	896,965 -108,296	-11%	-$14.1M	0.01%	809
2015 Q2	$77.8M	Buy	1,005,261 +51,421	+5%	+$3.37M	0.01%	997
2015 Q1	$55.2M	Sell	953,840 -92,151	-9%	-$3.91M	0.01%	1174
2014 Q4	$33.7M	Sell	1,045,991 -84,303	-7%	-$2.53M	﹤0.01%	1437
2014 Q3	$27.7M	Sell	1,130,294 -152,922	-12%	-$3.11M	﹤0.01%	1507
2014 Q2	$22.8M	Buy	1,283,216 +62,027	+5%	+$999K	﹤0.01%	1734
2014 Q1	$24.4M	Buy	1,221,189 +398,077	+48%	+$7.72M	﹤0.01%	1625
2013 Q4	$13.8M	Buy	823,112 +494,637	+151%	+$6.84M	﹤0.01%	2007
2013 Q3	$3.49M	Buy	328,475 +109,881	+50%	+$961K	﹤0.01%	2724
2013 Q2	$1.22M	Buy	+218,594	New	+$1.32M	﹤0.01%	3158

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

State Street's ANAC Position: Q2 2016 in Review

State Street sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 1,315,892 shares — an estimated $70.3M sold.

State Street first reported a position in ANAC in Q2 2013 and held it in 12 quarters. The position peaked at $112M in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

State Street reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
State Street sold 1,315,892 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $70.3M.
State Street first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2013 and held it in 12 quarters.
State Street's ANACOR PHARMACEUTICALS INC COM position peaked at $112M in Q4 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on State Street's 13F filing for Q2 2016, filed 12 Aug 2016.